Cure My Disease

Don't miss your cure!

 Log in / Sign up

Chlorhexidine dressing patch tested on healthy volunteers – no health benefit expected

NCT ID NCT01112020

Knowledge-focused Sponsor: C. R. Bard Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed Phase 1 study tested how much chlorhexidine gluconate (CHG) and a breakdown product called PCA remain in different dressing patches after 7 days on healthy volunteers. 45 participants had patches applied to 7 sites each. The study was not designed to treat or prevent any disease, but to understand the dressing's contents after use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chlorhexidine gluconate dressing patch

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

45 people

The number who actually took part.

Start date

Apr 2010

Finished

May 2010

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Able to read, review and sign the Informed Consent * Willing to shower using the same soap/cleansers from the Screening Visit through the end of the study * Use study-approved contraceptive methods Exclusion Criteria: * Participation in an investigational study within 28 days prior to dosing. * Clinically significant illness within 28 days prior to dosing. * History of allergic responses to chlorhexidine, chlorhexidine-containing products, glycerol, adhesives, latex * History of clinically significant skin disorders * History of Type I diabetes mellitus, insulin-dependent diabetes mellitus(IDDM) * History of significant dermatologic cancers (melanoma, squamous) * Known history of immunologic disorders * Use immunosuppressive or other proscribed medications * Use of skin products at the application site * Significant history of allergies to soaps, lotions, emollients, ointments, creams * History of drug or alcohol addiction within the past year * Pregnant, lactating, breast-feeding, or intends to become pregnant during the course of the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy

Contacts and locations

Locations

  • Cetero Research

    Saint Charles, Missouri, 63301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.